Article info
PDFSection 5: Patient safety and quality assurance
5PSQ-003 Effectiveness and safety of vedolizumab in ulcerative colitis and crohn’s disease
Citation
5PSQ-003 Effectiveness and safety of vedolizumab in ulcerative colitis and crohn’s disease
Publication history
- First published March 2, 2018.
Online issue publication
April 21, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions